Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report


  • Products Id :- F9462789-BA01-417E-8228-F31EE56D0CAE
  • |
  • Pages: 52
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ionis Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Ionis Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis or the company) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer's and Parkinson's disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia and Huntington's disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. Ionis is headquartered in Carlsbad, California, the US.

Scope

- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Company Snapshot 2

Table of Contents 5

Ionis Pharmaceuticals, Inc.: Company Overview 9

Ionis Pharmaceuticals, Inc.: Overview and Key Facts 9

Ionis Pharmaceuticals, Inc.: Overview 9

Ionis Pharmaceuticals, Inc.: Key Facts 9

Ionis Pharmaceuticals, Inc.: Key Employees 11

Ionis Pharmaceuticals, Inc.: Key Employee Biographies 12

Ionis Pharmaceuticals, Inc.: Major Products and Services 15

Ionis Pharmaceuticals, Inc.: Company History 16

Ionis Pharmaceuticals, Inc.: Management Statement 21

Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries 24

Ionis Pharmaceuticals, Inc.: Key Competitors 25

Ionis Pharmaceuticals, Inc.: Company Analysis 26

Ionis Pharmaceuticals, Inc.: Business Description 26

Ionis Pharmaceuticals, Inc.: SWOT Analysis 27

Ionis Pharmaceuticals, Inc.: SWOT Overview 27

Ionis Pharmaceuticals, Inc.: Strengths 27

Ionis Pharmaceuticals, Inc.: Weaknesses 28

Ionis Pharmaceuticals, Inc.: Opportunities 28

Ionis Pharmaceuticals, Inc.: Threats 29

Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity 31

Ionis Pharmaceuticals, Inc.: Financial Deals Overview 31

Ionis Pharmaceuticals, Inc.: Targets and Partners 33

Ionis Pharmaceuticals, Inc.: Top Deals 2014-2018YTD 35

Ionis Pharmaceuticals, Inc.: Advisors 36

Ionis Pharmaceuticals, Inc.: Top Legal Advisors 36

Ionis Pharmaceuticals, Inc.: Top Financial Advisors 36

Ionis Pharmaceuticals, Inc.: Corporate Venturing 37

Ionis Pharmaceuticals, Inc.: Capital Raising 38

Ionis Pharmaceuticals, Inc.: Partnership 39

Ionis Pharmaceuticals, Inc.: Divestments 40

Ionis Pharmaceuticals, Inc.: Private Equity and Ownership 41

Ionis Pharmaceuticals, Inc.: Recent Developments 42

Ionis Pharmaceuticals, Inc.: News and Events Summary 42

Ionis Pharmaceuticals, Inc.: Corporate Governance 45

Ionis Pharmaceuticals, Inc.: Financial Performance 46

Ionis Pharmaceuticals, Inc.: Market Developments 46

Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events 48

Ionis Pharmaceuticals, Inc.: Strategy and Operations 49

Appendix 50

Contact Us 50

Methodology 50

About MarketLine 51

List of Figures

Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD 2018)

Figure 4: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD 2018)

Figure 5: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD 2018)

Figure 6: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD 2018)

Figure 7: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 8: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Figure 9: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014-YTD 2018)

Figure 10: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014-YTD 2018)

Figure 11: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Figure 12: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)

List of Tables

Table 1: Ionis Pharmaceuticals, Inc.: Key Facts

Table 2: Ionis Pharmaceuticals, Inc.: Key Employees

Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors

Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM )

Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners

Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2014-2018YTD

Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (USD m)

Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (USD m)

Table 11: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD 2018)

Table 12: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD 2018)

Table 13: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD 2018)

Table 14: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD 2018)

Table 15: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Table 16: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Table 17: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014-YTD 2018)

Table 18: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014-YTD 2018)

Table 19: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Table 20: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)

Table 21: Ionis Pharmaceuticals, Inc.: News and Events Summary

Table 22: Ionis Pharmaceuticals, Inc.: Corporate Governance

Table 23: Ionis Pharmaceuticals, Inc.: Financial Performance

Table 24: Ionis Pharmaceuticals, Inc.: Market Developments

Table 25: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 26: Ionis Pharmaceuticals, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 175 INR 12250
Site License
USD 350 INR 24500
Corporate User License
USD 525 INR 36750

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com